Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
RLMD
Showing 2 of 12 quarters
Position history for RA Capital Management, L.P.'s holdings in Relmada Therapeutics, Inc.
No. RA Capital Management exited its RLMD (Relmada Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 2,947,369 shares worth $20.5M. RA Capital Management already held RLMD in its Q4 2019 13F, the earliest on record, and held it in 9 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$20.5M
Total Shares Change
-2.9M
Quarter-by-Quarter History